Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
NCT03401918Phase 2Completed
- Sponsor
- Stanford University
- Start
- Aug 2017
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of progesterone in recurrent pregnancy loss (RPL), Unexplained infertility, sponsored by Stanford University. Started Aug 2017; status: completed.
02
Drugs
progesterone
03
Conditions
recurrent pregnancy loss (RPL)Unexplained infertility
Beyond the preview
Go deeper on NCT03401918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401918.